🇺🇸 FDA
Pipeline program

SARS-CoV-2 mRNA Vaccine, Bivalent Low dose

LVRNA021-IIT-03

Unknown mab active

Quick answer

SARS-CoV-2 mRNA Vaccine, Bivalent Low dose for SARS-CoV-2 is a Unknown program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
SARS-CoV-2
Phase
Unknown
Modality
mab
Status
active

Clinical trials